Stay updated on Pembrolizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The change on the webpage possibly concerns Medical and healthcare-related publications and documentation.
    Difference
    30%
    Check dated 2024-05-22T11:56:26.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    16 days ago
    Change Detected
    Summary
    The value on the webpage has changed to 'Active, not recruiting'. This change indicates that the status of the clinical trial involving Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma (IMA950-106) has been updated to reflect that it is currently active but not recruiting participants.
    Difference
    100%
    Check dated 2024-05-10T08:47:59.000Z thumbnail image
  7. Check
    17 days ago
    Change Detected
    Summary
    The value 'Active, not recruiting' has recently changed to an unknown status.
    Difference
    85%
    Check dated 2024-05-09T06:28:02.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T23:16:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.